Spero Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.25

+0.01 (+0.45%)

As of Mar 31, 3:11 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,292.9% upside

Low Target $21.51

Average Target $31.34

High Target $48.77

Current Price $2.25

Current
$2.25

Target
$31.34

$21.51 $31.34 avg $48.77

Scenario Analysis

Bear Case

$21.51

856.0%

Low target

Base Case

$31.34

+1,292.9%

Avg target

Bull Case

$48.77

+2,067.6%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.22

-30.1% from high

52-Week Low

$0.51

+345.4% from low

Target vs 52W High

$31.34

+873.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%